Publications by authors named "Filip Vrbacky"

Claim this Profile
L
Late preterm prelabor rupture of membrane (>33 weeks): the risk of intraamniotic inflammation and fetal inflammation is influenced by the cervical microbial ecosystem and cervical inflammation.
Marian Kacerovsky, Filip Vrbacky, Jana Matulova, Radka Bolehovska, Rudolf Kukla

Am J Obstet Gynecol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaginal microbiota: different roles of lactobacilli and community instability in chronic vulvovaginal discomfort.
Vladimír Buchta, Jana Nekvindová, Daniel Leško, Filip Vrbacký, Peter Veščičík

Front Cell Infect Microbiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive Care Infection Score (ICIS) is an Early Marker for Infection in Time of Admission to Intensive Care Units.
Filip Vrbacký, Martin Blažek, Ilona Fátorová, Karolína Šímová, Pavel Žák

Int J Lab Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.
Laura Ondrisova, Vaclav Seda, Krystof Hlavac, Petra Pavelkova, Eva Hoferkova, Filip Vrbacky

J Clin Invest· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sysmex-derived COVID-19 prognostic score as an early prognostic marker for severity of the COVID-19 disease.
Martin Blažek, Filip Vrbacký, Ilona Fátorová, Klára Mirská, Pavel Žák

Int J Lab Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive Care Infection Score (ICIS) is elevated in patients with moderate and severe COVID-19 in the early stages of disease.
Filip Vrbacky, Ilona Fatorova, Martin Blazek, Petr Smahel, Pavel Zak

J Infect Public Health· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia.
Martin Šimkovič, Pavel Vodárek, Monika Motyčková, Dominika Écsiová, Petra Rozsívalová

Eur J Clin Invest· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group.
Anna Panovská, Lucie Němcová, Lucie Nekvindová, Martin Špaček, Martin Šimkovič

Hematol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma.
Ivana Baranova, Helena Kovarikova, Jan Laco, Iva Sedlakova, Filip Vrbacky

Clin Chem Lab Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved laboratory diagnostics of Streptococcus pneumoniae in respiratory tract samples through qPCR.
Rudolf Kukla, Radka Bolehovska, Jakub Radocha, Lenka Pliskova, Pavel Zak, Filip Vrbacky

New Microbiol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpes simplex virus resistant to acyclovir: A single-centre experience from the Czech Republic.
Miroslav Fajfr, Lenka Pliskova, Radka Bolehovská, Zuzana Uhlířová, Filip Vrbacký

J Glob Antimicrob Resist· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter.
Petra Belohlavkova, Katerina Steinerova, Michal Karas, Iva Skoumalova, Peter Rohon, Filip Vrbacky

Leuk Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?' Clinical Biochemistry 61 (2018) 34-39.
Lucie Petrova, Filip Vrbacky, Miriam Lanska, Alzbeta Zavrelova, Pavel Zak

Clin Biochem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?
Lucie Petrova, Filip Vrbacky, Miriam Lanska, Alzbeta Zavrelova, Pavel Zak

Clin Biochem· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients.
Petra Belohlavkova, Filip Vrbacky, Jaroslava Voglova, Zdenek Racil, Daniela Zackova

Arch Med Sci· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.
Monika Jaruskova, Nikola Curik, Rajna Hercog, Vaclava Polivkova, Eliska Motlova, Filip Vrbacky

J Exp Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Hana Plesingerova, Zuzana Librova, Karla Plevova, Antonin Libra, Boris Tichy, Filip Vrbacky

Leuk Lymphoma· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical microbiota in women with preterm prelabor rupture of membranes.
Marian Kacerovsky, Filip Vrbacky, Radka Kutova, Lenka Pliskova, Ctirad Andrys

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia.
Martin Šimkovič, Monika Motyčková, David Belada, Pavel Vodárek, Rahul Kapoor

Arch Med Sci· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case 2-2012: a 57-year-old woman with post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for primary myelofibrosis.
Milan Kost'ál, Pavel Zák, Eva Vejrazková, Melánie Cermanová, Petra Belohlávková

Acta Medica (Hradec Kralove)· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant change in ZAP-70 expression during the course of chronic lymphocytic leukemia.
Vladimira Vroblova, Filip Vrbacky, Monika Hrudkova, Karolína Jankovicova, Daniela Schmitzova

Eur J Haematol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological prognostic markers in chronic lymphocytic leukemia.
Vladimíra Vroblová, Lukás Smolej, Filip Vrbacký, Karolina Jankovicová, Monika Hrudková

Acta Medica (Hradec Kralove)· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis